International Reference Pricing in Medicare—A Mismatch Between Policy and Evaluation
This Viewpoint explores whether savings from lower drug prices outweigh any downstream effects on manufacturer behavior, patient access, and future pharmaceutical innovation.
Authors
- Mireille Jacobson (ORCID: https://orcid.org/0000-0002-4977-8783)
- Darius Noshir Lakdawalla (ORCID: https://orcid.org/0000-0001-5934-8042)
- Dana P. Goldman (ORCID: https://orcid.org/0000-0001-8498-6396)
Institutions
- University of Southern California (US)
- University of California, Los Angeles (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1001/jamahealthforum.2026.3845
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00